Inasmuch as the first phase-3 trial is expected to report data in 2015, MCUR ought to be able to raise cash on favorable terms if this trial is a success.
I own MCUR in the SI charity contest.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”